A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT03091257 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03091257
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2026-07-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.